Schedule 13G ownership disclosure

Enanta Pharmaceuticals Inc

Security class unavailable · CUSIP: 29251M106

Event date: 2018-05-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-18-003559
Form type
SC 13G
Filer
ENANTA PHARMACEUTICALS INC
CIK
CIK 1177648
Filed
May 10, 2018
Reporting period
May 02, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub